Cargando…
Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
COVID-19 has been declared a pandemic by the world health organization. Patients with cancer, and particularly hematologic malignancies may be at higher risk for severe complications due to their malignancy, immune dysregulation, therapy, and associated comorbidities. The oncology community has been...
Autores principales: | Assi, Tarek, Samra, Bachar, Dercle, Laurent, Rassy, Elie, Kattan, Joseph, Ghosn, Marwan, Houot, Roch, Ammari, Samy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348065/ https://www.ncbi.nlm.nih.gov/pubmed/32719749 http://dx.doi.org/10.3389/fonc.2020.01267 |
Ejemplares similares
-
Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
por: Ghosn, Marwan, et al.
Publicado: (2016) -
Optimizing the Management of Cancer Patients Treated With Systemic Therapies During the COVID-19 Pandemic: The New Role of PCR and CT Scan
por: Viansone, Alessandro A., et al.
Publicado: (2021) -
Learning by Debate: Innovative Tool in the Hematology-Oncology Fellowship Program
por: Samaha, Ramy, et al.
Publicado: (2021) -
Solitary Laryngeal Metastasis from Transitional Cell Carcinoma of the Kidney: Clinical Case and Review of the Literature
por: Assi, Tarek, et al.
Publicado: (2015) -
Targeting the VEGF Pathway in Osteosarcoma
por: Assi, Tarek, et al.
Publicado: (2021)